glp-1 data Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Medications for Weight Loss:

Taken together, weight loss induced bone loss represents a clinical challenge that is likely to be more prevalent as anti-obesity treatments become more widely available

doi: 10.1136/bmj-2023-076197 26 HigginsJPThompsonSGDeeksJJAltmanDG

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are synthetic analogs of the glucagon-like peptide-1 (GLP-1) hormone

13 , 15 Although the magnitude of this effect in clinical settings remains unclear, there is a biological rationale to consider an elevated risk of volume-related symptoms in susceptible individuals, such as older adults, those with orthostatic hypotension, or patients on multidrug antihypertensive regimens

They essentially amplify the bodys own satiety cues, Hardaway explained

Many patients explore switching from semaglutide to tirzepatide to access better efficacy despite higher costs